Fibrinogen as independent risk factor for ischemic stroke;Fibrinogênio como fator de risco independente de doença vascular cerebral

Arquivos de Neuro-Psiquiatria

Volumn 55, Issue 4, 1997, Pages 737-740

  Fukujima, Marcia Maiumi ^a   Da Rocha Martinez, Tânia Leme ^a   Do Espírito Santo De Almeida Pinto, Leonor ^a   Auriemo, Caio R C ^a   De Andrade, Luiz Augusto Franco ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Carotid ultrasonography; Cerebrovascular disease; Fibrinogen; Risk factor; Stroke

Indexed keywords

FIBRINOGEN;

ADULT; AGED; ARTICLE; BLOOD; BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; FEMALE; HUMAN; MALE; MIDDLE AGED; NONPARAMETRIC TEST; PHYSIOLOGY; RISK FACTOR; THROMBOEMBOLISM;

ADULT; AGED; BRAIN ISCHEMIA; CEREBROVASCULAR DISORDERS; FEMALE; FIBRINOGEN; HUMANS; INTRACRANIAL EMBOLISM AND THROMBOSIS; MALE; MIDDLE AGED; RISK FACTORS; STATISTICS, NONPARAMETRIC;

EID: 2442421150     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-282x1997000500009     Document Type: Article

References (18)

1. Cook NS, Ubben D. Fibrinogen as a major risk in cardiovascular disease. TIPS 1990;11: 444-451.
2. Ernst E, Matrai A, Marshall M. Blood rheology in patients with transient ischemic atacks. Stroke 1988,19: 624-636.
3. Ernst E, Resch KL. The "fibrinogen hypothesis": is elevated plasma fibrinogen a major cardiovascular risk factor? In Woodford FP, Davignon J, Sniderman A (eds). Atherosclerosis X. Amsterdam. Elsevier, 1995:785-792.
4. Ernst E, Resch KL, Matrai A, Buhl M, Schlosser P, Paulsen HF. Impaired blood rheology: a risk factor after stroke? J Intern Med 1991;229.457-462.
5. Fletcher AP, Alkjaersig N, Davis A, Lewis M Blood coagulation and plasma fibrinolitic enzyme system pathophysiology in stroke. Stroke 1976;7:337-348.
6. Grotta J, Ackerman R, Correia J, Fallick G, Chang J. Whole blood viscosity parameters and cerebral blood flow. Stroke 1982;13:296-301
7. Hamsten A, Iselius L, de Faire U, Blomback M Genetic and cultural inheritance of plasma fibrinogen concentration. Lancet 1987;2.988-990.
8. Heinrich J, Schulte H, Balleisen L, Assmann G, van de Loo J. Predictive. value of haemostatic variables in the PROCAM-study Thromb Haemostas 1991;65.815
9. Humphries SE, Cook M, Dubowitz M, Stirling Y, Meade TW Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations Lancet 1987,1:1452-1454.
10. Kannel WB, D'Agostinho RB, Belanger AJ. Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from The Framingham Study. Am Heart J 1987;113:1006-1010.
11. Kannel WB, Wolf PA, Castelli WP, D'Agostinho RB, Fibrinogen and risk of cardiovascular disease JAMA 1987;258 1183-1186
12. Mann KG. Blood coagulation: linkage between thombosis and atherosclerosis: an overview In Woodford FP, Davignon J, Sniderman A (eds) Atherosclerosis X. Amsterdam: Elsevier, 1995:780-784.
13. Meade TW, Brozovic M, Chakrabarti RR, et al., Haemostatic funcion and ischaemic heart disease: principal results of the Northwick Park Heart Study Lancet 1986;2:533-537.
14. Pilgeram LO, Chee AN, von dem Bussche G. Evidence for abnormalities in clotting and thrombolysis as a risk factor for stroke. Stroke 1973;4:643-657.
15. Sadoshima S, Tanaka K. Fibrinogen and low density lipoprotein in the development of cerebral atherosclerosis. Atherosclerosis 1979;34 93-103.
16. Todd M, McDevitt E, McDowell F Stroke and blood coagulation Stroke 1973;4:400-405.
17. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984;311:501-505.
18. Whisnant JP, Basford JR, Bernstein EF et al., Special report from the National Institute of Neurological Disorders and Stroke: Classification of Cerebrovascular Disease III Stroke 1990,21.637-676